Results 71 to 80 of about 19,767 (298)
Patients With Pituitary Neuroendocrine Tumours Requiring Neurosurgery –Who Is Referring Them?
Clinical Endocrinology, EarlyView.ABSTRACT Objective Patients living with pituitary neuroendocrine tumours (PitNETs) present with a spectrum of clinical manifestations and often follow a circuitous route to diagnosis, resulting in diagnostic delays. The objective of this study is to identify and report the various sources of referrals for patients who underwent pituitary resection for ...
Doua S. Ahmed +11 more
wiley +1 more source
Management of prolactinoma during pregnancy and postpartum
Journal of Integrated Health Sciences, 2015 Prolactinoma is classified as microprolactinoma when it measures
Om J Lakhani +3 more
doaj +1 more source
The birth and rise of a craniopharyngioma: the radiological evolution of an incidental craniopharyngioma detected on serial MRI during medical treatment of a macroprolactinoma [PDF]
, 2016 This case demonstrates the rare coexistence of a prolactinoma with craniopharyngioma and documents its radiological growth. This case suggests that patients with pituitary neoplasms should be followed closely and although prolactinomas can often be ...
Losa, Marco +3 more
core +1 more source
Equine Veterinary Education, EarlyView.Summary Background Pituitary pars intermedia dysfunction (PPID) is commonly treated with pergolide mesylate, a dopamine receptor agonist. Cabergoline is a dopamine receptor agonist that has shown activity on prolactin secretion in horses for up to 10 days.
H. Hess +5 more
wiley +1 more source
Cell Death and Disease, 2019 As the commonest type of functional pituitary tumor, prolactinoma takes up around 40–60% of functional pituitary tumors. Despite dedications attributed to the treatment of prolactinoma, complete cure remains difficult.
Chao Wang +7 more
semanticscholar +1 more source
AIP variant causing familial prolactinoma
Pituitary, 2020 Pathogenic variants in the aryl hydrocarbon receptor-interacting protein ( AIP ) gene are increasingly recognised as a cause of familial isolated pituitary adenoma. AIP -associated tumours are most commonly growth hormone (GH) producing. In our cohort of
D. Carty +7 more
semanticscholar +1 more source
A Retrospective Study on the Impact of Primary Aldosteronism in Pregnancy (H.A.P.P.I. Study Group)
Clinical Endocrinology, Volume 104, Issue 2, Page 113-122, February 2026.ABSTRACT Objective Primary aldosteronism (PA) is a common cause of hypertension in young women. However, there is a paucity of data regarding its impact during pregnancy. The primary objective of this study was to describe the occurrence of hypertensive disorders of pregnancy (HDP) in PA.
Diana Oprea +7 more
wiley +1 more source
AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center. [PDF]
, 2019 Background: Pituitary adenomas have a high disease burden due to tumor growth/ invasion and disordered hormonal secretion. Germline mutations in genes such as MEN1 and AIP are associated with early onset of aggressive pituitary adenomas that can be ...
Cano González, David A. +2 more
core
Predictors of dopamine agonist resistance in prolactinoma patients
BMC Endocrine Disorders, 2020 Background Surgical resection of prolactinomas resistant to dopamine agonists is frequently incomplete due to fibrotic changes of the tumour under pharmacological therapy. In order to identify a subgroup of patients who may benefit from early surgery, we
E. Vermeulen +6 more
semanticscholar +1 more source